AI-generated · cited to primary sources · not investment advice
Sika Interplant (523606) Mar 2024 Filing Analysis
How durable is the business?
The Engineering Systems segment saw explosive growth of 110.73% YoY, increasing its share of total revenue from ~34% to ~40.7%. (2 expanding)
“Sale of Engineering Systems: 4,314.87 (2023-24) vs 2,047.59 (2022-23)”
The company maintained its focus on in-house R&D for import substitution, with R&D expenditure increasing by 4.88% YoY. (1 stable, 1 expanding)
“The expenditure incurred on Research and Development during the year was ₹ 102.03 lakhs.”
See the full cited Business Model analysis of Sika Interplant
What could break the thesis?
The risk is easing. The debt-to-equity ratio improved slightly to 0.18 times from 0.20 times in the previous year, and the company reports having no long-term debt as of the balance sheet date. (2 easing)
“The debt equity ratio of the Company improved slightly to 0.18 times (FY 2021-22: 0.20 times).”
The risk is stable. Management notes that the nature of Aerospace & Defence involves complex technologies where certification cycles often extend longer than planned, affecting revenue timing. (2 stable)
“given the nature of the A&D business, the products and systems involved are typically of complex advanced technologies, often resulting in the approval and certification cycle extending for materially longer than originally planned. This can result in delays in production orders and consequent deliveries, affecting the timing of revenues.”
See the full cited Risk analysis of Sika Interplant
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.